Found 326 matching trials
Treatment of Relapsed and/or Chemotherapy Refractory Advanced Malignancies by CART-meso PHASE1 RATIONALE: Placing a tumor antigen chimeric receptor that has been created ...
Show More Location
Biotherapeutic Department and Pediatrics Department of Chinese PLA General Hospital
Learn More & Join Trial
Micro RNA as Prediction and/or Prognostic Markers of IRIS in TB-HIV Co-infected Patients N/A The role of miRNAs in HIV disease is yet to be completely defined. Host miR...
Show More Location
Institut Pasteur du Cambodge
Learn More & Join Trial
Safety and Efficacy of GYA01 (CART84) in Relapsed/Refractory (R/R) Acute Myeloid Leukemia (AML) and Acute Lymphoblastic T Leukemia Patients (T-ALL). PHASE1 This Phase I/IIa clinical study is testing an experimental treatment called...
Show More Location
Hospital Clínic de Barcelona
Learn More & Join Trial
PD1 Integrated Anti-PSMA CART in Treating Patients With Castrate-Resistant Prostate Cancer PHASE1 PD1-PSMA-CART in Treating Patients With Castrate-Resistant Prostate Cancer...
Location
The First Affiliated Hospital, Zhejiang University
Learn More & Join Trial
Treatment of Chemotherapy Refractory Human Epidermalgrowth Factor Receptor-2( HER-2) Positive Advanced Solid Tumors PHASE1 RATINALE: Placing a tumor antigen chimeric receptor that has been created i...
Show More Location
Chinese PLA General Hospital
Learn More & Join Trial
Anti-BCMA or/and Anti-CD19 CART Cells Treatment of Relapsed Multiple Myeloma PHASE1 This phase I trial studies the side effects and best dose of BCMA CART cell...
Show More Location
Shenzhen Second People's Hospital,The first affiliated hospital of Shenzhen University
Learn More & Join Trial
UCAR-T Targeting CD19/BCMA in Subjects With Autoantibody-Mediated Autoimmune Benign Hematological Diseases EARLY_PHASE1 This is a single-arm, open-label, investigator-initiated trial (IIT) design...
Show More Location
Union Hospital, Tongji Medical College, Huazhong University of Science & Technology
Learn More & Join Trial
Testing the Addition of an Experimental Medication MK-3475 (Pembrolizumab) to Usual Anti-Retroviral Medications in Patients With HIV and Cancer PHASE1 This phase I trial studies the side effects of pembrolizumab in treating pa...
Show More Location
University of Alabama at Birmingham Cancer Center
Learn More & Join Trial
Research In Viral Eradication of HIV Reservoirs PHASE2 This study will be a two-arm prospective 1:1 randomised controlled trial co...
Show More Location
Brighton and Sussex University Hospitals NHS Trust
Learn More & Join Trial
Safety and Efficacy of CAR-T Cell Therapy for Relapsed/refractory Neuroblastoma and Desmoplastic Small Round Cell Tumors: a Single-arm, Open-label Trial. PHASE1 Title: Safety and efficacy of CAR-T cell therapy for relapsed/refractory ne...
Show More Location
Sun Yat-sen University Cancer Center
Learn More & Join Trial